by Sam Eskandari | Jan 10, 2018 | News
January 10, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”) is pleased to announce that its research arm, Cannevert Therapeutics Ltd. (“CTL“) has signed a clinical research agreement with...
by Sam Eskandari | Jan 5, 2018 | News
January 4, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”) is pleased to provide an update to its prospective and current Veritas Shareholders regarding the Company’s activities and milestones over...
by Sam Eskandari | Jan 3, 2018 | News
NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) — NetworkNewsAudio, via NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, today announces the online availability...
by Sam Eskandari | Jan 2, 2018 | News
VANCOUVER, British Columbia, Jan. 02, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Brian O’Connor, a consultant in respiratory medicine, has joined its advisory board. He is a...
